Acyclic, Monocyclic, and Bicyclic Monoterpenes Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 15 substances referred to collectively as the Acyclic, Monocyclic, and Bicyclic Monoterpenes Group.
|Substance group||CAS RN||Common name||DSL name||Draft screening assessment||Risk management scope||Proposed conclusion on section 64 criteria||Follow-up activities|
|Acyclic, Monocyclic, and Bicyclic Monoterpenes Group||8015-77-8Table 1 footnote a,Table 1 footnote b||Bois de rose oil||Oils, bois de rose||HTML||None||Does not meet||None planned at this time|
|8014-19-5Table 1 footnote a,Table 1 footnote b||Palmarosa oil||Oils, palmarosa|
|8000-46-2Table 1 footnote a,Table 1 footnote b||Geranium oil||Oils, geranium|
|8008-52-4Table 1 footnote a||Coriander oil||Oils, coriander|
|8007-01-0Table 1 footnote a||Rose oil||Oils, rose||HTML||Meets one or more of the criteria||Refer to risk management scope|
|8007-02-1Table 1 footnote a||Lemongrass oil||Oils, lemongrass||None||Does not meet||None planned at this time|
|1113-21-9||Geranyllinalool||1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetramethyl-, (E,E)-|
|8008-31-9Table 1 footnote a,Table 1 footnote b||Mandarin oil||Oils, mandarin||HTML||Meets one or more of the criteria||Refer to risk management scope|
|8016-85-1Table 1 footnote a,Table 1 footnote b||Tangerine oil||Oils, tangerine|
|8008-57-9Table 1 footnote a||Sweet orange oil||Oils, orange, sweet||None||Does not meet||None planned at this time|
|8006-64-2Table 1 footnote a||Turpentine oil||Turpentine, oil||HTML||Meets one or more of the criteria||Refer to risk management scope|
|9005-90-7Table 1 footnote a,Table 1 footnote b||Turpentine||Turpentine|
|8021-28-1Table 1 footnote a,Table 1 footnote b||Fir oil||Oils, fir||None||Does not meet||None planned at this time|
|8002-09-3Table 1 footnote a||Pine oil||Oils, pine|
|March 2021||Anticipated publication of the final screening assessment.|
|March 14, 2020||Publication and start of 60-day public comment period on the Draft Screening Assessment for the Acyclic, Monocyclic, and Bicyclic Monoterpenes Group and the Risk Management Scope for Certain Terpenes and Terpenoids within the Acyclic, Monocyclic and Bicyclic Monoterpenes Group, Specifically: Rose Oil, Mandarin Oil, Tangerine Oil, Turpentine Oil, and Turpentine. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 11.|
This screening assessment focuses on 15 substances referred to as the Acyclic, Monocyclic, and Bicyclic Monoterpenes Group, which are a part of a larger group of 76 substances referred to collectively under the Chemicals Management Plan as the Terpenes and Terpenoids Group.
Four of these 76 substances were subsequently determined to be of low concern to both human health and the environment through other approaches. Conclusions for CAS RNs 25428-43-7 and 4572-09-2 are provided in the Final Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure. Conclusions for CAS RNs 29350-73-0 and 68916-97-2 are provided in the Final Screening Assessment of Substances Identified as Being of Low Concern using the Ecological Risk Classification of Organic Substances and the Threshold of Toxicological Concern (TTC)-based Approach for Certain Substances.
Sixteen of these 76 substances (CAS RNs 495-62-5, 8001-61-4, 8007-08-7, 17627-44-0, 65113-99-7, 107898-54-4, 87-44-5, 88-84-6, 3691-12-1, 4630-07-3, 68917-29-3, 489-86-1, 639-99-6, 22451-73-6, 8006-87-9, and 489-84-9) were assessed as a part of the Monocyclic and Bicyclic Sesquiterpenes Group.
Decisions on the remaining 41 substances will be communicated in separate risk assessments.
Report a problem or mistake on this page
- Date modified: